INHSU 2026

6-9 OCTOBER 2026

Clarion Congress Hotel Prague
Czech Republic

The 14th International Conference
on Health and Hepatitis
in Substance Users

Register now

 

INHSU 2026 Co-Conveners and Committees

 

Our conference would not be possible without the tireless knowledge and expertise of our local co-conveners, international executive committee, program committee, and other committees. Thank you to everyone involved. 

Executive Committee

 

The INHSU 2025 Executive Committee provides strategic oversight and guidance for the conference, helping to shape the program, support decision-making, and ensure the event reflects the needs and priorities of the local and global community. 

Marie Jauffret Roustide, Research Fellow, Institut national de la santé et de la recherche médicale (Inserm)

Martin Kaberg, Associate Professor, Stockholm Centre for Dependency Disorders/Karolinska Institutet

Alexei Lakhov, Executive Director, European Network of People who Use Drugs (EuroNPUD)

Anna Meteliuk, Project Manager, Research Alliance For Public Health

Viktor Mravcik, Assoc. Prof. & Director of Research and Innovations, Společnost Podané ruce

Emma Day, Executive Director, INHSU

Professor Jason Grebely, The Kirby Institute, UNSW Sydney and President, INHSU, Australia

 Professor Natasha Martin, University of California San Diego, United States

 

Program Committee

 

The INHSU 2026 Program Committee is responsible for developing the conference program and ensuring the content is relevant, high-quality, and reflective of the diverse experiences and expertise across the network.

  • Mia Biondi, Nurse Practitioner, University of Toronto
  • David Goodman-Meza, Senior Research Associate, Kirby Institute, UNSW Sydney
  • Louise Hansford, Hepatitis C Elimination Coordinator, South for the NHS APA (NHS Substance Addiction Providers Alliance)
  • Gillian Kolla, Assistant Professor of Population Health and Applied Health Sciences, Memorial University
  • Dr Andrew Scheibe, Technical Advisor, TBHIV Care
  • Scientia Professor Carla Treloar, Centre for Social Research in Health and the Social Policy Research Centre, UNSW Sydney
  • Peter Vickerman, Professor in Infectious Disease Modelling, University of Bristol

Program Advisory Committee

The Program Advisory Committee is internationally representative, reflecting diverse regions, sectors, and lived experience, and provides input on program themes, topics, and speakers.

  • Anton Basenko, Executive Director, International Network of People who Use Drugs (INPUD)
  • Monica Ciupagea, Expert Drug Use and HIV, UNODC
  • Maria Corcorran, Physician, Clinton Health Access Initiative (CHAI)
  • Tetiana Deshko, Director, International Programs Alliance for Public Health
  • Melisa Dickie, Director, Hepatitis C Knowledge Exchange CATIE
  • Soňa Fraňková, Senior Hepatologist, Institute for Clinical and Experimental Medicine, Prague
  • Helena Gherasim, Deputy Director in the Field of Cooperation Společnost Podané ruce
  • Kanishk Gupta, Market Shaping Officer, PATH
  • Petr Husa Department Head, Department of Infectious Diseases Masaryk University Faculty of Medicine
  • Leo Jefferys, Acting Executive Director European Network of People who Use Drugs (EuroNPUD)
  • Lucia Kiššová, Director of the Drug Policy Department, Government Council for Addiction Policy Coordination
  • Eliza Kurcevič-Ramonė, European Union Drugs Agency (EUDA)
  • Lise Lafferty, Senior Research Fellow Centre for Social Research in Health
  • Niklas Luhmann
  • Antons Mozalevskisis, Medical Officer, WHO Regional Office For Europe
  • Jiri Richter, Executive Director, Social Worker, SANANIM
  • Katrin Schiffer, Director, Coorelation-European Harm Reduction Network (C-EHRN)
  • Laurie Schowalter, Lead, Programmes, Frontline AIDS
  • Mark Stoove, Head of Public Health, Head of Justice Health Research, Burnet Institute
  • Karin Timmermans, Technical Manager, Strategy UNITAID
  • Petr Urbanek, Head of the Internal Medicine, Clinic University Hospital Prague
  • Alex Wade, Clinical Nurse Consultant, Mid North Coast Liver Clinics, North Coast HARP
  • John Ward, Senior Scientist, US Centers for Disease Control and Prevention (CDC)
  • Ernst Wisse, Harm Reduction Advisor, Medecins Du Monde